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Abstract
Background & objective: Sickle cell anemia (SCA) is well recognized as a chronic inflammatory disease. Despite progress in 
therapy, SCA remains a cause of  significant morbidity and mortality. The relationship between exercise and immune function 
has been of  great interest to the scientific community and the lay public. The aim of  this study was to measure the impact of  
aerobic exercise training on the immunologic parameters and inflammatory cytokines of  patients with sickle cell anemia (SCA) 
in asymptomatic steady state. 
Material and methods: Sixty asymptomatic sickle cell anemia patients were involved in this study, their age ranged from 25- 40 
years and were assigned to two sub-groups; group (A) received aerobic exercise training for 12 weeks, however group (B) re-
ceived no training intervention for 12 weeks. Parameters of  CD3, CD4 and CD8 were quantified, Leukocyte, differential counts, 
IL-6 and TNF-α were measured before and after 12 weeks, at the end of  the study.
Results: The mean values of  CD3, CD4 and CD8, leukocyte, monocytes counts, IL-6 and TNF-α were significantly decreased in 
group (A), while group (B) showed non-significant changes in these parameters. Also; there were significant differences between 
mean levels of  the investigated parameters in group (A) and group (B) after treatment. 
Conclusion: The current study provides evidence that aerobic exercise training improves inflammatory markers and immune 
system in patients with sickle cell anemia (SCA) in asymptomatic steady state.
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Introduction
Sickle cell anemia (SCA) is now the world’s most com-
mon genetic defect. It is estimated that 5% of  the popu-
lation carries a haemoglobinopathy trait worldwide, there 
are an estimated 300,000 babies born annually worldwide 
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with a severe hemoglobin disorder1. Despite the signifi-
cant increase in research and number of  published arti-
cles, many aspects of  the pathophysiology of  the disease 
and its complications remain elusive2.
 
Sickle cell anemia (SCA) is a chronic condition presenting 
in people homozygous for hemoglobin S (HbS)3. Tissue 
ischemia due to vascular occlusion causing infarctive tis-
sue damage, which in turn initiates secondary inflamma-
tory responses4,5.  
 
People with SCA are also at a higher risk of  stroke, acute 
chest syndrome, leg ulcers, pulmonary hypertension, and 
other complications6. Although SCA generally is a be-
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nign and asymptomatic state, red blood cell sickling and 
splenic infarction can occur at low oxygen levels such as 
at high altitudes7. Causes of  death among patients with 
SCA include cardiopulmonary causes such as cardiac ar-
rest, heart failure, and pulmonary embolism, infections, 
stroke, and multi-organ failure8. Life expectancy in HbS 
from a multicenter study in the USA in 1994 was estimat-
ed at 42 for men and 48 for women9. African children 
with SCA mortality is still high as an early-life mortality 
of  50%–90% among children born in Africa with SCA10.
 
Sickle cell disease has a deleterious effect on immune 
system functions, and thus children with SCA are at in-
creased risk of  life-threatening infections, especially with 
Streptococcus pneumoniae and Haemophilus influenzae11. More-
over, infection has long been recognized as one of  the 
most common precipitants of  crisis in SCA12.
 
As there is limitation in studies reporting the benefits of  
aerobic exercises on immune system response among pa-
tients with sickle cell anemia (SCA). This study aimed to 
examine effects of  aerobic exercise training on selected 
inflammatory markers and immune parameters among 




Sixty sickle cell anemia Saudi patients in stable state that 
presented at the Haematology Department, King Abdal-
aziz University Hospital, were recruited into the study. 
Cases were selected from patients whose blood samples 
were submitted to the hematology section for hemoglo-
bin electrophoresis, which was either advised by their 
treating doctor or was performed to confirm a positive 
sickling test. All confirmed patients of  sickle cell hae-
moglobinopathy diagnosed by presence of  Hemoglobin 
‘S’ band on hemoglobin electrophoresis and only homo-
zygous Sickle cell disease patients (patients whose elec-
trophoresis showed presence of  Haemoglobin ‘S’ band 
with or without Haemoglobin ‘F’ band – HbSS genotype) 
were included in the study. Each patient was assessed 
clinically to confirm steady state. The steady state was de-
fined as the period free of  crisis extending from at least 
three weeks since the last clinical event and three months 
or more since the last blood transfusion, to at least one 
week before the start of  a new clinical event. Some de-
mographic data (age, gender, weight and height) of  both 
the subjects and controls were also documented.
 
Exclusion criteria included sickle cell disease patient with 
concurrent HIV or overt infection. Also, SCA patient 
with painful vaso-occlusive crisis (VOC) with bone or 
joint pain, or multiple sites of  pain, necessitating hospital 
admission and analgesic administration. Participants were 
divided into two groups; group (A) received treadmill aer-
obic exercise training on treadmill. However, group (B) 
received no exercise training. The CONSORT diagram 
outlining the details of  the screening, run-in and ran-
domization phases of  the study and reasons for partici-
pant exclusion can be found in figure (1). All participants 
signed the informed consent.
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Methods
Measurements
The following measurements were taken before the study 
and after 3 months, at the end of  the study.
A. Inflammatory cytokines: 
Blood samples were drained from the antecubital vein af-
ter a 12-h fasting, the blood samples were centrifuged at 
+ 4 °C (1000 = g for 10 min). Interleukin-6 (IL-6) level 
was analyzed by “Immulite 2000” immunassay analyzer 
(Siemens Healthcare Diagnostics, Deerfield, USA). How-
ever, tumor necrosis factor-alpha (TNF-α) was measured 
by ELISA kits (ELX 50) in addition to ELISA microplate 
reader (ELX 808; BioTek Instruments, USA). All analyses 
were done by Hitachi 7170 Autoanalyser (Tokyo, Japan) 
and kits (Randox).
B. Analysis of  peripheral blood cells: 
The analysis of  peripheral blood cells (e.g., total and dif-
ferential count) was performed on a Beckman Coulter 
AcT 5diff  hematology analyzer. The values were ex-
pressed in percentages and absolute numbers.
C. Flow cytometry analysis: 
The human leukocyte differentiation antigens CD3, CD4 
 
                                       Figure (1): Subjects screening and recruitment  CONSORT diagram. 
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and CD8 (Beckman Coulter, Marseille, France)  Five mi-
croliters of  appropriate monoclonal antibody was added 
to 50 µL of  a whole-blood sample and incubated for 15 
minutes at room temperature. Thereafter, the erythrocytes 
were lysed with 125 µL of  a lysing solution, OptiLyse C, 
for 10 minutes. The reaction was stopped by the addition 
of  250 µL phosphate-buffered saline. The samples were 
analyzed by flow cytometry using Cytomics FC 500 and 
CXP software (Beckman Coulter).The leukocyte subsets 
were defined by forward- and side-scatter pattern. The 
negative control value was determined by a fluorescence 
background and antibody-nonspecific staining.
Procedures
Following the previous evaluation, all patients enrolled 
randomly into the following groups:
1. The training group (Group A) received aerobic exercise 
training for 12-weeks on the treadmill (Enraf  Nonium, 
Model display panel Standard, NR 1475.801, Holand) 
which was conducted according to recommendation of  
aerobic exercise application approved by the American 
College of  Sports Medicine13. Training program included 
5 minutes for warming –up in the form of  range motion 
and stretching exercises, 30 minutes of  aerobic exercise 
training with intensity equal 60-70% of  the individual 
maximum heart rate followed by cooling down for 10 
minutes (on treadmill with low speed and without incli-
nation). Participants had 3 sessions /week for 3 months 
with close supervision of  a physical therapist.
2. The control group (Group B) received no exercise in-
tervention.
Statistical analysis
The mean values of  the investigated parameters obtained 
before and after three months in both groups were com-
pared using paired "t" test. Independent "t" test was used 
for the comparison between the two groups (P<0.05).
Results
The two groups were considered homogeneous regard-
ing the demographic variables (table 1). The mean age 
of  group (A) was 25.16±7.14 years, and the mean age 
of  group (B) was 24.54±7.63 years. There were no sig-
nificant differences in weight, height, body mass index 
(BMI), systolic blood pressure and diastolic blood pres-
sure between both groups.
Table 1: Comparison of demographic variables between both groups. 
 
  Group (A) Group (B) Significance 
Age (year) 26.54 ± 6.73 24.91 ±  7.32 P>0.05 
Weight (kg) 38.76 ± 8.65 40.13 ± 10.11 P>0.05 
Height (cm) 167.42 ± 10.21 166.85 ± 9.37 P>0.05 
BMI (kg/m2) 18.56 ± 3.18 19.74 ± 3.25 P>0.05 
SBP (mmHg) 116.71 ± 10.24 118.27 ± 12.57 P>0.05 
DBP (mmHg) 75.83 ± 6.22 78.61 ± 5.73 P>0.05 
     BMI: Body Mass Index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure.    
There was a 28.1%, 24.7%, 33.1%, 32.8%, 36.2%, 35.3%, 
20.3% and 37.2% reduction in mean values of   tumor 
necrosis factor-α (TNF-α), interleukin-6 (IL-6), white 
blood cells count, total neutrophil count,  Monocytes , 
CD3 count , CD4 count  and CD8 count respectively  in 
the training group (table 2). 
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Table 2: Mean value and significance of TNF- α, IL-6, white blood cells count,  total 
neutrophil count , monocytes,  CD3 count , CD4 count and CD8 count in group 
(A) before and at the end of the study. 
  
  
Mean + SD 
t- value Significance 
Pre Post 
TNF-α (pg/mL) 4.51 ± 1.63* 3.24 ± 1.35 6.88 P <0.05 
IL-6 (pg/mL) 2.34 ± 0.92* 1.76 ± 0.85 5.76 P <0.05 
WBC count  (109/µL) 9.17 ± 3.87* 6.13 ± 2.92 7.14 P <0.05 
Total neutrophilcount 
(109/µL) 6.33 ± 2.62* 4.25 ± 2.31 6.28 P <0.05 
Monocytes (109/µL) 0.58 ±0.14* 0.37 ±0.11 5.24 P <0.05 
CD3 count (109/L) 1.95 ± 0.87* 1.26 ± 0.72 4.23 P<0.05 
CD4 count (109/L) 1.52 ± 0.75* 1.21 ± 0.61 4.35 P <0.05 
CD8 count (109/L) 0.86 ± 0.27* 0.54 ± 0.13 4.12 P <0.05 
TNF-α: tumor necrosis factor – alpha; IL-6: Interleukin-6; WBC: white blood cells; (*) indicates a significant difference between 
the two groups, P < 0.05. 
While, there was a 3.4%, 3.7%, 2.5%, 2.1%, 3.7%, 6.5%, 
6.3% and 5.4% increase in mean values of  the same vari-
ables in the control group. The mean values of  TNF-α, 
IL-6, white blood cells count,  total neutrophil count , 
monocytes,  CD3 count, CD4 count and CD8 count de-
creased significantly in the training group, however the 
results of  the control group were not significant (table 
3). Also, there were significant differences between both 
groups at the end of  the study (table 4).
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Table 3: Mean value and significance of TNF-α, IL-6, white blood cells count, 
total neutrophil count, monocytes, CD3 count, CD4 count and CD8 count in 
group (B) before and after the study. 
  
  
Mean + SD t- 
value Significance Pre Post 
TNF-
α (pg/mL) 4.38 ± 1.51 4.53 ± 1.55 1.24 P>0.05 
IL-6 (pg/mL) 2.16 ± 0.83 2.24 ± 0.85 1.16 P>0.05 
WBC 




6.18 ± 2.45 6.31 ± 2.48 1.15 P>0.05 
Monocytes (109/µL) 0.54 ± 0.16 0.56 ± 0.17 0.98 P>0.05 
CD3 count(109/L) 1.83 ± 0.91 1.95 ± 0.98 0.85 P>0.05 
CD4 count(109/L) 1.41 ± 0.85 1.50 ± 0.93 0.72 P>0.05 
CD8 count(109/L) 0.73 ± 0.26 0.77 ± 0.34 0.68 P>0.05 
TNF-α: tumor necrosis factor – alpha; IL-6: Interleukin-6; WBC: white blood cells; (*) indicates a significant difference 
between the two groups, P < 0.05. 
  
  
Table 4: Mean value and significance of TNF-α, IL-6, white blood cells count, 
total neutrophil count, monocytes, CD3 count, CD4 count and CD8 count in 
group (A) and group (B) at the end of the study. 
  
  
Mean + SD t- 
value Significance Group (A) Group (B) 
TNF-
α (pg/mL) 3.24 ± 1.35* 4.53 ± 1.55 6.17 P <0.05 
IL-6 (pg/mL) 1.76 ± 0.85* 2.24 ± 0.85 5.38 P <0.05 
WBC 




4.25 ± 2.31* 6.31 ± 2.48 5.88 P <0.05 
Monocytes (109/µL) 0.37 ±0.11* 0.56 ± 0.17 4.36 P <0.05 
CD3 count(109/L) 1.26 ± 0.72* 1.95 ± 0.98 3.91 P <0.05 
CD4 count(109/L) 1.21 ± 0.61* 1.50 ± 0.93 3.65 P <0.05 
CD8 count(109/L) 0.54 ± 0.13* 0.77 ± 0.34 3.76 P <0.05 
TNF-α: tumor necrosis factor – alpha; IL-6: Interleukin-6; WBC: white blood cells; (*) indicates a significant difference 
between the two groups, P < 0.05. 
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Discussion
Sickle cell disease is well recognized as a chronic inflam-
matory disease14 as cytokines are elevated in steady state15. 
It is widely accepted that physical exercise may bring 
about changes in the immune system. Despite the high 
interpersonal variation, it is widely accepted that physical 
exercise may promote changes in the immune system21,22.
 
To our knowledge, this is the first study addressing an-
thropometric, inflammatory and immunological param-
eters of  patients with SCA after 12 weeks of  concurrent 
training. We observed increased markers of  immune sys-
tem and reduction of  markers of  systemic inflammation. 
We also observed lower levels of  CD3, CD4 and CD8, 
Leukocyte, differential counts, IL-6 and TNF-α after 12 
weeks of  concurrent aerobic training. The results of  our 
study agreed with several previous studies suggesting that 
aerobic exercise promotes the modulation of  immune 
system systemic inflammation.
Kohut  et al. randomly assigned  a group of  elderly to either 
an aerobic exercise treatment or a flexibility/strength ex-
ercise treatment 3 days/week, 45 min/day for 10 months. 
Aerobic exercise treatment group experienced significant 
reductions in serum CRP and IL-6 compared to flexibili-
ty/strength exercise treatment group, whereas TNF-α de-
clined in both groups23. Also, Shih and colleagues report-
ed significant reductions in all anthropometric, metabolic, 
interleukin-6 and C-reactive protein after completion of  
12-week exercise program24. Similarly, Goldhammer  and 
colleagues  found significant reduction in CRP and IL-6 
among twenty-eight patients with coronary heart disease 
following a 12-week aerobic exercise training program26. 
In addition, Mattusch et al. found 9 months of  marathon 
training (n=12) to reduce CRP levels by 31%, with no 
change in the non-training control group (n=10)29. While, 
Hayashino and colleagues checked fourteen randomized 
controlled trials (824 patients with type 2 diabetes) were 
included in their meta-analysis. Exercise was associated 
with a significant in CRP and IL-625. The three possible 
mechanisms of  exercise anti-inflammatory effects include 
reduction in visceral fat mass34; reduction in the circulat-
ing numbers of  pro-inflammatory monocytes35 and an 
increase in the circulating numbers of  regulatory T cells36.
A major finding of  this work is that aerobic exercise 
training may restore immune function among patients 
with SCA. The results of  our study are compatible with 
several previous studies suggesting  that exercise training 
promotes the modulation of  immune system markers. 
Woods et al.  found that 6 months of  supervised aero-
bic exercise training (composed of  30-minutes of  brisk 
walking 3 times/week) in the elderly increased T-cell pro-
liferation compared to controls in previously sedentary 
elderly37. While, Kursat et al. concluded that regular and 
moderate aerobic exercise on treadmill for 30 minutes 
has favorable effects on the immune system by increasing 
immunoglobulines (IgA, IgG and IgM levels ) which are 
potent protective factors38. Also, Buyukyazi proved that 
baseline NK cell percentage, and serum IgA and IgM 
concentrations were significantly higher among eleven el-
derly male athletes performing regular aerobic exercise for 
about 4.4 ± 1.4 day/week for 10.0 ± 8.1 hour/week than 
eleven male individuals at similar ages leading a sedentary 
life who were taken as a control group39. Moreover, the 
possible mechanisms of  exercise immune system modu-
lating effects include decreased levels of  pro-inflammato-
ry cytokines TNF-α42,IL-6 43 and C-reactive protein44 
along with an increase in the interleukin -10 (IL-10)43.
The current study has important strengths and limita-
tions. The major strength is the supervised nature of  the 
study. Supervising physical activity removes the need to 
question compliance or to rely on activity questionnaires. 
Further, all exercise sessions were supervised and adher-
ence to the activities was essentially 100%. Moreover, the 
study was randomized; hence, we can extrapolate adher-
ence to the general population. On the other hand, the 
major limitations is only patients with sickle cell anemia 
(SCA) in asymptomatic steady state  were enrolled in the 
study, so the value of  this study is only related to SCA 
in asymptomatic steady state, also a small sample size in 
both groups may limit the possibility of  generalization of  
the findings in the present study. Finally, within the limit 
of  this study, aerobic exercise training is recommended 
for  modulation of  low grade systemic inflammation and 
immune system among patients with SCA in asymptom-
atic steady state. Further researches are needed to explore 
the impact of  aerobic exercise training on quality of  life 
and other biochemical parameters among patients with 
SCA.
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Conclusion
The current study provides evidence that aerobic exercise 
training improves inflammatory markers and immune 
system in patients with sickle cell anemia (SCA) in as-
ymptomatic steady state.
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